These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23471500)

  • 1. Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model.
    Rosso F; Quagliariello V; Tortora C; Di Lazzaro A; Barbarisi A; Iaffaioli RV
    J Mater Sci Mater Med; 2013 Jun; 24(6):1473-81. PubMed ID: 23471500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
    Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
    Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.
    Lin T; Yuan A; Zhao X; Lian H; Zhuang J; Chen W; Zhang Q; Liu G; Zhang S; Chen W; Cao W; Zhang C; Wu J; Hu Y; Guo H
    Acta Biomater; 2017 Apr; 53():427-438. PubMed ID: 28213097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft.
    Souchek JJ; Wojtynek NE; Payne WM; Holmes MB; Dutta S; Qi B; Datta K; LaGrange CA; Mohs AM
    Acta Biomater; 2018 Jul; 75():323-333. PubMed ID: 29890268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication and characterization of cross-linkable hydrogel particles based on hyaluronic acid: potential application in vocal fold regeneration.
    Sahiner N; Jha AK; Nguyen D; Jia X
    J Biomater Sci Polym Ed; 2008; 19(2):223-43. PubMed ID: 18237494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
    Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
    Choi KY; Chung H; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Jeong SY
    Biomaterials; 2010 Jan; 31(1):106-14. PubMed ID: 19783037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
    Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
    Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ synthesis of luminescent carbon nanoparticles toward target bioimaging.
    Sharker SM; Kim SM; Lee JE; Jeong JH; In I; Lee KD; Lee H; Park SY
    Nanoscale; 2015 Mar; 7(12):5468-75. PubMed ID: 25732701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of nanoparticles based on histidine-hyaluronic acid conjugates as doxorubicin carriers.
    Wu JL; Liu CG; Wang XL; Huang ZH
    J Mater Sci Mater Med; 2012 Aug; 23(8):1921-9. PubMed ID: 22580754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and biodistribution of a theranostic aluminum phthalocyanine nanophotosensitizer.
    Asem H; El-Fattah AA; Nafee N; Zhao Y; Khalil L; Muhammed M; Hassan M; Kandil S
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():48-57. PubMed ID: 26708297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin Based Nanoparticles for Detection of Pancreatic Cancer Cells.
    Karaca N; Ünlüer ÖB
    Protein Pept Lett; 2019; 26(4):271-280. PubMed ID: 30659529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles.
    Durán-Lobato M; Muñoz-Rubio I; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L
    J Biomed Nanotechnol; 2014 Jun; 10(6):1068-79. PubMed ID: 24749401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
    Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
    J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor.
    Phua SZF; Yang G; Lim WQ; Verma A; Chen H; Thanabalu T; Zhao Y
    ACS Nano; 2019 Apr; 13(4):4742-4751. PubMed ID: 30964974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.